PMID- 29478298 OWN - NLM STAT- MEDLINE DCOM- 20191206 LR - 20230124 IS - 1600-6143 (Electronic) IS - 1600-6135 (Linking) VI - 18 IP - 9 DP - 2018 Sep TI - Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation. PG - 2261-2273 LID - 10.1111/ajt.14710 [doi] AB - Fc-dependent effector mechanisms may contribute to antibody-mediated rejection (ABMR), and distinct gene polymorphisms modifying the function of Fc gamma receptors (FcgammaRs) may influence the capability of donor-specific antibodies (DSAs) to trigger inflammation. To evaluate the relevance of functional FcgammaR variants in late ABMR, 85 DSA-positive kidney allograft recipients, who were recruited upon antibody screening of 741 prevalent patients, were genotyped for polymorphisms in FcgammaRIIA (FCGR2A-H/R(131) ; rs1801274), FcgammaRIIIA (FCGR3A-V/F(158) ; rs396991), and FcgammaRIIIB (FCGR3B-neutrophil antigen 1 ([NA1]/NA2; rs35139848). Individuals with high-affinity FCGR3A-V(158) alleles (V/V(158) or V/F(158) ) showed a higher rate (and extent) of peritubular capillaritis (ptc) in protocol biopsies than homozygous carriers of the lower-affinity allele (ptc score >/=1: 53.6% vs 25.9%; P = .018). Associations were independent of C1q-binding to DSA or capillary C4d. In parallel, there was a trend toward increased macrophage- and injury-repair response-associated transcript subsets. Kidney function over 24 months, however, was not different. In support of a functional role of FcgammaRIIIA polymorphism, NK92 cells expressing FCGR3A-V(158) produced >2 times as much interferon gamma upon incubation with HLA antibody-coated cells as those expressing FCGR3A-F(158) . FcgammaRIIA and FcgammaRIIIB polymorphisms were not associated with allograft morphology. Our data suggest that the presence of high-affinity FcgammaRIIIA variants may favor DSA-triggered microcirculation inflammation. CI - (c) 2018 The American Society of Transplantation and the American Society of Transplant Surgeons. FAU - Arnold, M L AU - Arnold ML AD - Department of Internal Medicine 3, Institute for Clinical Immunology, Friedrich-Alexander University, Erlangen-Nuremberg, Germany. FAU - Kainz, A AU - Kainz A AD - Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria. FAU - Hidalgo, L G AU - Hidalgo LG AD - Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada. FAU - Eskandary, F AU - Eskandary F AD - Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria. FAU - Kozakowski, N AU - Kozakowski N AD - Department of Pathology, Medical University of Vienna, Vienna, Austria. FAU - Wahrmann, M AU - Wahrmann M AD - Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria. FAU - Haslacher, H AU - Haslacher H AD - Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. FAU - Oberbauer, R AU - Oberbauer R AD - Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria. FAU - Heilos, A AU - Heilos A AD - Department of Paediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria. FAU - Spriewald, B M AU - Spriewald BM AD - Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander University, Erlangen-Nuremberg, Germany. FAU - Halloran, P F AU - Halloran PF AD - Alberta Transplant Applied Genomics Centre, ATAGC, University of Alberta, Edmonton, AB, Canada. FAU - Bohmig, G A AU - Bohmig GA AD - Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180330 PL - United States TA - Am J Transplant JT - American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons JID - 100968638 RN - 0 (FCGR2A protein, human) RN - 0 (FCGR3A protein, human) RN - 0 (FCGR3B protein, human) RN - 0 (GPI-Linked Proteins) RN - 0 (Isoantibodies) RN - 0 (Receptors, IgG) SB - IM MH - Adult MH - Cross-Sectional Studies MH - Female MH - Follow-Up Studies MH - GPI-Linked Proteins/genetics MH - Genotype MH - Graft Rejection/*diagnosis/etiology MH - Graft Survival MH - Humans MH - Inflammation/*diagnosis/etiology MH - Isoantibodies/*adverse effects MH - Kidney Failure, Chronic/genetics/surgery MH - Kidney Transplantation/*adverse effects MH - Male MH - Microcirculation MH - Middle Aged MH - *Polymorphism, Genetic MH - Postoperative Complications MH - Prognosis MH - Receptors, IgG/*genetics MH - Risk Factors MH - Tissue Donors OTO - NOTNLM OT - alloantibody OT - genetics OT - histocompatibility OT - kidney transplantation/nephrology OT - protocol biopsy OT - rejection: antibody-mediated (ABMR) OT - translational research/science EDAT- 2018/02/27 06:00 MHDA- 2019/12/18 06:00 CRDT- 2018/02/26 06:00 PHST- 2017/12/15 00:00 [received] PHST- 2018/02/02 00:00 [revised] PHST- 2018/02/16 00:00 [accepted] PHST- 2018/02/27 06:00 [pubmed] PHST- 2019/12/18 06:00 [medline] PHST- 2018/02/26 06:00 [entrez] AID - S1600-6135(22)09698-8 [pii] AID - 10.1111/ajt.14710 [doi] PST - ppublish SO - Am J Transplant. 2018 Sep;18(9):2261-2273. doi: 10.1111/ajt.14710. Epub 2018 Mar 30.